Breaking News Instant updates and real-time market news.

ALNY

Alnylam

$70.30

1.73 (2.52%)

06:40
10/06/16
10/06
06:40
10/06/16
06:40

Alnylam selloff a buying opportunity, says Piper Jaffray

Piper Jaffray analyst Edward Tenthoff views today's selloff in shares of Alnylam Pharmaceuticals after the company discontinued its revusiran program as a buying opportunity. The analyst does not believe the discontinuation has read-through to the Phase III APOLLO trial or seven other RNAi drugs that employ ESC-GalNAc technology. He lowered his price target for Alnylam shares to $106 from $118 and keeps an Overweight rating on the name. JPMorgan and Barclays this morning downgraded the shares.

  • 14

    Oct

  • 06

    Nov

ALNY Alnylam
$70.30

1.73 (2.52%)

09/15/16
09/15/16
INITIATION
Target $82

Underperform
FBR calls Alexion overvalued, starts shares at Underperform
FBR Capital analyst Christopher James initiated coverage of Alexion Pharmaceuticals (ALXN) with an Underperform rating and $82 price target. The biotech focused on patients with ultra-rare disorders closed yesterday up $2.63 to $129.42. Alexion shares are overpriced as the company is facing a competitive near-term landscape, particularly from Alnylam's (ALNY) ALN-CC5, James tells investors in a research note. Further, near-term expansion into additional indications will be challenging given the recent failed study with eculizumab in refractory generalized myasthenia gravis, the analyst contends. He also sees possible pricing pressures from biosimilars, including an Amgen (AMGN) biosimilar product in development. James this morning also initiated Achillion Pharmaceuticals (ACHN) and Arena Pharmaceuticals (ARNA) with Outperform ratings.
09/28/16
JANY
09/28/16
INITIATION
Target $74
JANY
Neutral
Alnylam initiated with a Neutral at Janney Capital
Janney Capital analyst Roy Buchanan initiated Alnylam with a Neutral and a $74 fair value estimate. The analyst is not confident about the outcome for the pivotal study for patisiran in transthyretin familial amyloid neuropathy, expected in about 12 months, and give patisiran a 50% chance of success.
10/06/16
LEHM
10/06/16
DOWNGRADE
Target $50
LEHM
Equal Weight
Alnylam downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Geoff Meacham downgraded Alnylam Pharmaceuticals (ALNY) to Equal Weight saying he views other SMid cap biotech names as more attractive following the company's recent pipeline setbacks. The analyst removed Revusiran sales from his Alnylam model after the program was discontinued yesterday and he cut his price target for the shares to $50 from $85. Meacham lists Neurocrine (NBIX), Prothena (PTRA) and Incyte (INCY) as names he finds more attractive over the next 12 months. Alnylam is trading down 44% in pre-market trading to $39.25.
10/06/16
JPMS
10/06/16
DOWNGRADE
Target $51
JPMS
Neutral
Alnylam downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Anupam Rama downgraded Alnylam Pharmaceuticals to Neutral after the company said it will discontinue Revusiran for the treatment of Familial Amyloid Cardiomyopathy. The analyst viewed the drug as a "key asset" and cut his price target for the shares to $51 from $83. Barclays this morning also downgraded Alnylam.

TODAY'S FREE FLY STORIES

BHF

Brighthouse Financial

$55.46

-0.21 (-0.38%)

12:30
11/21/17
11/21
12:30
11/21/17
12:30
Options
$2.7M premium block in Brighthouse Financial as shares advance »

$2.7M premium block in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRUE

TrueCar

$11.29

0.14 (1.26%)

12:28
11/21/17
11/21
12:28
11/21/17
12:28
Recommendations
TrueCar analyst commentary  »

TrueCar Q3 miss a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$34.56

-0.08 (-0.23%)

, TWX

Time Warner

$89.76

2.05 (2.34%)

12:28
11/21/17
11/21
12:28
11/21/17
12:28
General news
On The Fly: Top stock stories at midday »

Stocks opened sharply…

T

AT&T

$34.56

-0.08 (-0.23%)

TWX

Time Warner

$89.76

2.05 (2.34%)

JEC

Jacobs Engineering

$65.09

5.75 (9.69%)

MDT

Medtronic

$82.96

4.06 (5.15%)

CPB

Campbell Soup

$46.14

-3.79 (-7.59%)

DSW

DSW

$19.57

-2.96 (-13.14%)

SIG

Signet Jewelers

$55.48

-20.36 (-26.85%)

CYTK

Cytokinetics

$11.10

-0.7 (-5.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 29

    Nov

  • 01

    Dec

  • 07

    Dec

  • 08

    Dec

HPQ

HP Inc.

$22.59

0.465 (2.10%)

12:25
11/21/17
11/21
12:25
11/21/17
12:25
Options
HP Inc. call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

12:20
11/21/17
11/21
12:20
11/21/17
12:20
General news
U.S. equities are back at record highs »

U.S. equities are back at…

KORS

Michael Kors

$56.29

0.14 (0.25%)

12:19
11/21/17
11/21
12:19
11/21/17
12:19
Hot Stocks
Michael Kors to hire Francesca Leoni as new Chief Brand Officer »

Michael Kors Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

TSRO

Tesaro

$83.54

-2.36 (-2.75%)

12:18
11/21/17
11/21
12:18
11/21/17
12:18
Recommendations
Tesaro analyst commentary  »

Tesaro financing removes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

$NSD

NASDAQ Market Internals

12:17
11/21/17
11/21
12:17
11/21/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEP

PepsiCo

$115.81

0.9 (0.78%)

, KHC

Kraft Heinz

$79.93

0.3 (0.38%)

12:16
11/21/17
11/21
12:16
11/21/17
12:16
Periodicals
PepsiCo speculated as possible Kraft Heinz target, FT says »

CreditSights suggests…

PEP

PepsiCo

$115.81

0.9 (0.78%)

KHC

Kraft Heinz

$79.93

0.3 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
11/21/17
11/21
12:16
11/21/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$26.70

-0.04 (-0.15%)

12:10
11/21/17
11/21
12:10
11/21/17
12:10
Options
Size ratio call spread adds 50K contracts to Bank of America volume »

Size ratio call spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$83.54

-2.36 (-2.75%)

12:08
11/21/17
11/21
12:08
11/21/17
12:08
Hot Stocks
Tesaro higher after announcing 'non-dilutive' financing »

Tesaro announced earlier…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

SU

Suncor

$35.28

0.34 (0.97%)

12:05
11/21/17
11/21
12:05
11/21/17
12:05
Options
Suncor call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

12:00
11/21/17
11/21
12:00
11/21/17
12:00
General news
FX Action: USD-CAD »

FX Action: USD-CAD pulled…

11:55
11/21/17
11/21
11:55
11/21/17
11:55
General news
Treasury's $13 B 2-year FRN stopped at a high discount margin of 0.035% »

Treasury's $13 B…

TRIP

TripAdvisor

$30.48

-0.11 (-0.36%)

11:50
11/21/17
11/21
11:50
11/21/17
11:50
Options
TripAdvisor calls outpace puts 10:1 as shares see relative strength »

TripAdvisor calls outpace…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDS.A

Royal Dutch Shell

$61.70

-0.02 (-0.03%)

11:48
11/21/17
11/21
11:48
11/21/17
11:48
Conference/Events
Royal Dutch Shell to hold a meeting »

2017 Management Day will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKRX

Akorn

11:48
11/21/17
11/21
11:48
11/21/17
11:48
Periodicals
Akorn spokesperson tells Bloomberg no change with Fresenius SE deal »

As previously reported,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$109.11

1.735 (1.62%)

11:45
11/21/17
11/21
11:45
11/21/17
11:45
Earnings
On The Fly: What to watch in Salesforce earnings report »

Salesforce (CRM) is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

11:45
11/21/17
11/21
11:45
11/21/17
11:45
General news
Euro$ interest rate futures continue to recline »

Euro$ interest rate…

JNJ

Johnson & Johnson

$138.81

0.88 (0.64%)

11:44
11/21/17
11/21
11:44
11/21/17
11:44
Hot Stocks
Janssen announces submission of sBLA to expand indication for Darzalex »

Janssen Biotech, one of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

BLMN

Bloomin' Brands

$20.54

2.27 (12.42%)

11:40
11/21/17
11/21
11:40
11/21/17
11:40
Hot Stocks
Bloomin' Brands says will consider JANA Partners' perspectives »

Bloomin' Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAGP

Plains GP Holdings

$20.85

-0.04 (-0.19%)

11:40
11/21/17
11/21
11:40
11/21/17
11:40
Options
Call writer opens a notable new position in Plains GP Holdings »

Call writer opens a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$194.10

0.9 (0.47%)

, T

AT&T

$34.49

-0.155 (-0.45%)

11:34
11/21/17
11/21
11:34
11/21/17
11:34
Hot Stocks
FCC chairman Ajit Pai circulates draft Restoring Internet Freedom Order »

FCC chairman Ajit Pai…

NFLX

Netflix

$194.10

0.9 (0.47%)

T

AT&T

$34.49

-0.155 (-0.45%)

VZ

Verizon

$46.31

0.105 (0.23%)

CHTR

Charter

$338.37

-3.17 (-0.93%)

CMCSA

Comcast

$35.83

-0.33 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

MU

Micron

$47.64

1.48 (3.21%)

11:30
11/21/17
11/21
11:30
11/21/17
11:30
Options
Large four-way spread in Micron as shares see strength »

Large four-way spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 19

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.